These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1426 related items for PubMed ID: 19451803

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
    Trombetta M, Julian T, Bhandari T, Werts ED, Miften M, Parda D.
    Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
    [Abstract] [Full Text] [Related]

  • 3. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, Dipetrillo T, Khan D, Hudes R.
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term followup of breast preservation by re-excision and balloon brachytherapy after ipsilateral breast tumor recurrence.
    Trombetta M, Hall M, Julian TB.
    Brachytherapy; 2014 Oct; 13(5):488-92. PubMed ID: 24950822
    [Abstract] [Full Text] [Related]

  • 6. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer.
    Harms W, Krempien R, Hensley FW, Berns C, Fritz P, Wannenmacher M.
    Strahlenther Onkol; 2002 Nov; 178(11):607-14. PubMed ID: 12426671
    [Abstract] [Full Text] [Related]

  • 7. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):489-95. PubMed ID: 16246495
    [Abstract] [Full Text] [Related]

  • 8. The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer.
    Chadha M, Feldman S, Boolbol S, Wang L, Harrison LB.
    Brachytherapy; 2008 Feb 01; 7(1):22-8. PubMed ID: 18299110
    [Abstract] [Full Text] [Related]

  • 9. The use of the MammoSite balloon applicator in re-irradiation of the breast.
    Trombetta M, Julian T, Miften M, McWilliams W, Kim Y, Parda D.
    Brachytherapy; 2008 Feb 01; 7(4):316-9. PubMed ID: 18786865
    [Abstract] [Full Text] [Related]

  • 10. Partial breast brachytherapy as the primary treatment for breast cancer diagnosed after mantle radiation therapy for Hodgkin's disease.
    Chadha M, Yoon H, Feldman S, Shah N, Moore E, Harrison LB.
    Am J Clin Oncol; 2009 Apr 01; 32(2):132-6. PubMed ID: 19307955
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
    Póti Z, Nemeskéri C, Fekésházy A, Sáfrány G, Bajzik G, Nagy ZP, Bidlek M, Sinkovics I, Udvarhelyi N, Liszkay G, Repa I, Galuska L, Trón L, Mayer A, Esik O.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1022-33. PubMed ID: 15001241
    [Abstract] [Full Text] [Related]

  • 13. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
    Chao KK, Vicini FA, Wallace M, Mitchell C, Chen P, Ghilezan M, Gilbert S, Kunzman J, Benitez P, Martinez A.
    Int J Radiat Oncol Biol Phys; 2007 Sep 01; 69(1):32-40. PubMed ID: 17467920
    [Abstract] [Full Text] [Related]

  • 14. Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy.
    Benitez PR, Chen PY, Vicini FA, Wallace M, Kestin L, Edmundson G, Gustafson G, Martinez A.
    Am J Surg; 2004 Oct 01; 188(4):355-64. PubMed ID: 15474426
    [Abstract] [Full Text] [Related]

  • 15. Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the mammosite balloon breast brachytherapy catheter using a 2-day dose schedule.
    Wallace M, Martinez A, Mitchell C, Chen PY, Ghilezan M, Benitez P, Brown E, Vicini F.
    Int J Radiat Oncol Biol Phys; 2010 Jun 01; 77(2):531-6. PubMed ID: 19775830
    [Abstract] [Full Text] [Related]

  • 16. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS.
    Head Neck; 2004 May 01; 26(5):389-95. PubMed ID: 15122654
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer.
    Kaufman SA, DiPetrillo TA, Price LL, Midle JB, Wazer DE.
    Brachytherapy; 2007 May 01; 6(4):286-92. PubMed ID: 17991625
    [Abstract] [Full Text] [Related]

  • 18. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.
    Harper JL, Jenrette JM, Vanek KN, Aguero EG, Gillanders WE.
    Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):169-74. PubMed ID: 15629608
    [Abstract] [Full Text] [Related]

  • 19. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R, Peintinger F, Kopp M, Menzel C, Kogelnik HD, Sedlmayer F.
    Strahlenther Onkol; 2004 Jan 01; 180(1):38-44. PubMed ID: 14704843
    [Abstract] [Full Text] [Related]

  • 20. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer.
    Richards GM, Berson AM, Rescigno J, Sanghavi S, Siegel B, Axelrod D, Bernik S, Scarpinato V, Mills C.
    Ann Surg Oncol; 2004 Aug 01; 11(8):739-46. PubMed ID: 15249336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.